Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced it will join the epilepsy community at the 13th Annual Sofie's Journey Epilepsy Awareness Day & Education Expo at ...

Jazz Pharmaceuticals delivered a quarter that exceeded Wall Street’s expectations, with management attributing results to ...

University of Mississippi researchers have developed a new tool to help scientists study how environmental and genetic ...

This is a type of science that has an impact that most people could see in their homes,” said Erin Hecht, a canine researcher ...

Many medications can cause memory loss, including benzodiazepines, opioids, certain antidepressants, and antihistamines.

“Without appropriate guidance, many dogs either forget or never learn how to have basic manners, leading to problem behaviors ...

For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be difficult to find lasting relief. Patients with a severe epileptic condition ...

The Brain and Spine Program at Intermountain Primary Children’s Hospital has been ranked 16th in the nation among all ...

A groundbreaking study published on November 3, 2025, has unveiled an intriguing connection between human brains and stock ...

A turning point for Rafael Yuste, a neuroscientist at New York's Columbia University, came when his lab discovered it could ...

Tropical cyclones—also known as hurricanes, typhoons or storms, depending on their location and intensity—are among the world's most destructive and costly climate disasters.

Announced positive results from two pivotal Phase 3 Essential3 studies of ulixacaltamide HCl in essential tremor (ET); Pre-NDA meeting with FDA ...